- Home
- OTTR vs GH Comparison
OTTR vs GH Comparison
Compare OTTR & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTTR
- GH
- Stock Information
- Founded
- OTTR 1907
- GH 2011
- Country
- OTTR United States
- GH United States
- Employees
- OTTR N/A
- GH N/A
- Industry
- OTTR Electric Utilities: Central
- GH Medical Specialities
- Sector
- OTTR Utilities
- GH Health Care
- Exchange
- OTTR Nasdaq
- GH Nasdaq
- Market Cap
- OTTR 3.5B
- GH 3.0B
- IPO Year
- OTTR N/A
- GH 2018
- Fundamental
- Price
- OTTR $75.37
- GH $24.87
- Analyst Decision
- OTTR
- GH Strong Buy
- Analyst Count
- OTTR 0
- GH 17
- Target Price
- OTTR N/A
- GH $39.31
- AVG Volume (30 Days)
- OTTR 217.8K
- GH 2.2M
- Earning Date
- OTTR 08-05-2024
- GH 11-04-2024
- Dividend Yield
- OTTR 2.47%
- GH N/A
- EPS Growth
- OTTR 14.71
- GH N/A
- EPS
- OTTR 7.40
- GH N/A
- Revenue
- OTTR $1,361,773,000.00
- GH $643,810,000.00
- Revenue This Year
- OTTR $6.51
- GH $27.01
- Revenue Next Year
- OTTR $4.52
- GH $18.30
- P/E Ratio
- OTTR $10.26
- GH N/A
- Revenue Growth
- OTTR N/A
- GH 26.20
- 52 Week Low
- OTTR $68.96
- GH $15.81
- 52 Week High
- OTTR $100.84
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- OTTR 28.27
- GH 39.97
- Support Level
- OTTR $75.64
- GH $23.48
- Resistance Level
- OTTR $78.94
- GH $25.87
- Average True Range (ATR)
- OTTR 2.46
- GH 1.16
- MACD
- OTTR -0.97
- GH -0.06
- Stochastic Oscillator
- OTTR 1.90
- GH 24.05
About OTTR Otter Tail Corporation
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.